Sphinganine

Sphinganine is a lipid of Sphingolipids (SP) class. Sphinganine is associated with abnormalities such as Sphingolipidoses, CLEFT LIP, CONGENITAL HEALED, Aortic aneurysm, familial thoracic 4, Morphologically altered structure and Atherosclerosis. The involved functions are known as Transcription, Genetic, Signal, Muscle Contraction, biological adaptation to stress and Gene Expression. Sphinganine often locates in Tissue membrane, Membrane, Protoplasm, Plasma membrane and Cytoplasmic. The associated genes with Sphinganine are SLC33A1 gene, HM13 gene, P4HTM gene, SPHK1 gene and SPHK2 gene. The related lipids are Sphingolipids, Phosphatidylserines, Sterols, Fatty Acids and inositolphosphorylceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Sphinganine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphinganine?

Sphinganine is suspected in Pulmonary Edema, Morphologically altered structure, Infection, HIV Infections, Pulmonary Hypertension, Exanthema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphinganine

MeSH term MeSH ID Detail
Abortion, Spontaneous D000022 12 associated lipids
Body Weight D001835 333 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Swine Diseases D013553 16 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with Sphinganine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphinganine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphinganine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphinganine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphinganine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphinganine?

Knock-out

Knock-out are used in the study 'Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast.' (Watanabe R et al., 2002) and Knock-out are used in the study 'Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.' (Jenkins GM and Hannun YA, 2001).

Mouse Model

Mouse Model are used in the study 'Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.' (Hu W et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphinganine

Download all related citations
Per page 10 20 50 100 | Total 790
Authors Title Published Journal PubMed Link
Zhao YY et al. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. 2012 Clin. Chim. Acta pmid:22227165
Martínez G et al. Plasma free fatty acids in mitochondrial fatty acid oxidation defects. 1997 Clin. Chim. Acta pmid:9469249
Bibel DJ et al. Topical sphingolipids in antisepsis and antifungal therapy. 1995 Clin. Exp. Dermatol. pmid:8593716
Bodennec J et al. Differential labelling of sphingolipids by [3H]serine and ([3H]methyl)-methionine in fish leukocytes. 2000 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:10904865
Siow D and Wattenberg B The compartmentalization and translocation of the sphingosine kinases: mechanisms and functions in cell signaling and sphingolipid metabolism. 2011 Crit. Rev. Biochem. Mol. Biol. pmid:21864225
Ribar S et al. Sphingoid bases as possible diagnostic parameters. 2003 Croat. Med. J. pmid:12698507
Jiang LH et al. Properties and therapeutic potential of transient receptor potential channels with putative roles in adversity: focus on TRPC5, TRPM2 and TRPA1. 2011 Curr Drug Targets pmid:21291387
Taouji S et al. Current Screens Based on the AlphaScreen Technology for Deciphering Cell Signalling Pathways. 2009 Curr. Genomics pmid:19794881
Takakuwa N et al. Isolation and characterization of the genes encoding delta(8)-sphingolipid desaturase from Saccharomyces kluyveri and Kluyveromyces lactis. 2002 Curr. Microbiol. pmid:12402089
Radner FP et al. Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease. 2011 Dermatoendocrinol pmid:21695016
Uchida Y The role of fatty acid elongation in epidermal structure and function. 2011 Dermatoendocrinol pmid:21695014
Roff CF et al. Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. 1991 Dev. Neurosci. pmid:1817037
Schmitz-Peiffer C Targeting ceramide synthesis to reverse insulin resistance. 2010 Diabetes pmid:20876726
Straczkowski M et al. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. 2007 Diabetologia pmid:17724577
Morales PR et al. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation. 2007 Drug Chem Toxicol pmid:17613006
Guillas I et al. C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. 2001 EMBO J. pmid:11387200
Vallée B and Riezman H Lip1p: a novel subunit of acyl-CoA ceramide synthase. 2005 EMBO J. pmid:15692566
Zanolari B et al. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae. 2000 EMBO J. pmid:10856228
Séror SJ et al. A mutant cysteinyl-tRNA synthetase affecting timing of chromosomal replication initiation in B. subtilis and conferring resistance to a protein kinase C inhibitor. 1994 EMBO J. pmid:8194536
Walther TC et al. Pkh-kinases control eisosome assembly and organization. 2007 EMBO J. pmid:18034155
Reggiori F et al. Lipid remodeling leads to the introduction and exchange of defined ceramides on GPI proteins in the ER and Golgi of Saccharomyces cerevisiae. 1997 EMBO J. pmid:9218793
Meyer zu Heringdorf D et al. Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. 1998 EMBO J. pmid:9582276
Nelson DH and Murray DK Dexamethasone and sphingolipids inhibit concanavalin A stimulated glucose uptake in 3T3-L1 fibroblasts. 1988-1989 Endocr. Res. pmid:3074919
Clarke BL et al. Regulation of parathyroid hormone release by protein kinase-C is dependent on extracellular calcium in bovine parathyroid cells. 1993 Endocrinology pmid:8440177
Riley RT et al. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. 2001 Environ. Health Perspect. pmid:11359699
Haschek WM et al. Fumonisin toxicosis in swine: an overview of porcine pulmonary edema and current perspectives. 2001 Environ. Health Perspect. pmid:11359693
Gelderblom WC et al. Toxicity of culture material of Fusarium verticillioides strain MRC 826 to nonhuman primates. 2001 Environ. Health Perspect. pmid:11359695
Merrill AH et al. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. 2001 Environ. Health Perspect. pmid:11359697
Missmer SA et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. 2006 Environ. Health Perspect. pmid:16451860
Koeller CM and Heise N The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease. 2011 Enzyme Res pmid:21603271
Bosson R et al. Incorporation of ceramides into Saccharomyces cerevisiae glycosylphosphatidylinositol-anchored proteins can be monitored in vitro. 2009 Eukaryotic Cell pmid:19074599
Vijai Kumar Reddy T et al. Design, synthesis and in vitro biological evaluation of short-chain C12-sphinganine and its 1,2,3-triazole analogs as potential antimicrobial and anti-biofilm agents. 2016 Eur J Med Chem pmid:27128176
Kobayashi T et al. Metabolism of free sphingoid bases in murine tissues and in cultured human fibroblasts. 1989 Eur. J. Biochem. pmid:2606103
Chigorno V et al. Metabolic processing of gangliosides by human fibroblasts in culture--formation and recycling of separate pools of sphingosine. 1997 Eur. J. Biochem. pmid:9461288
Berg C et al. Platelets induce reactive oxygen species-dependent growth of human skin fibroblasts. 2003 Eur. J. Cell Biol. pmid:14703013
Cukkemane N et al. Anti-adherence and bactericidal activity of sphingolipids against Streptococcus mutans. 2015 Eur. J. Oral Sci. pmid:26094809
Ramachandran S et al. The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids. 2009 Eur. J. Pharmacol. pmid:19285059
Tibboel J et al. Amelioration of hyperoxia-induced lung injury using a sphingolipid-based intervention. 2013 Eur. Respir. J. pmid:23143542
Lee S et al. Quantitative analysis of sphingomyelin by high-performance liquid chromatography after enzymatic hydrolysis. 2012 Evid Based Complement Alternat Med pmid:22919412
Ahn EH and Schroeder JJ Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells. 2002 Exp. Biol. Med. (Maywood) pmid:11976405
Ahn EH et al. Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents. 2006 Exp. Biol. Med. (Maywood) pmid:17060688
Wispriyono B et al. A role for the de novo sphingolipids in apoptosis of photosensitized cells. 2002 Exp. Cell Res. pmid:12213223
Dolgachev V et al. Reactive oxygen species generation is independent of de novo sphingolipids in apoptotic photosensitized cells. 2003 Exp. Cell Res. pmid:12915133
Porpaczy Z et al. Internalized plasma membrane cholesterol passes through an endosome compartment that is distinct from the acid vesicle-lysosome compartment. 1997 Exp. Cell Res. pmid:9260888
Duan J et al. Dietary sphingolipids improve skin barrier functions via the upregulation of ceramide synthases in the epidermis. 2012 Exp. Dermatol. pmid:22621186
Paragh G et al. Novel sphingolipid derivatives promote keratinocyte differentiation. 2008 Exp. Dermatol. pmid:18631249
Lee WJ et al. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. 2004 Exp. Mol. Med. pmid:15557814
Cerbon J et al. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation. 2009 Exp. Parasitol. pmid:19249300
Kaneider NC et al. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor. 2004 FASEB J. pmid:15208267
Waters CM et al. Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. 2006 FASEB J. pmid:16319133
Bu S et al. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. 2006 FASEB J. pmid:16278291
Gude DR et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. 2008 FASEB J. pmid:18362204
Ashkenazi A et al. Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1. 2012 FASEB J. pmid:22872679
Peer M et al. Pseudomonas syringae infection triggers de novo synthesis of phytosphingosine from sphinganine in Arabidopsis thaliana. 2010 FEBS Lett. pmid:20732322
Lahiri S et al. Kinetic characterization of mammalian ceramide synthases: determination of K(m) values towards sphinganine. 2007 FEBS Lett. pmid:17977534
Takeda H et al. Sphingomyelinase and ceramide inhibit formation of F-actin ring in and bone resorption by rabbit mature osteoclasts. 1998 FEBS Lett. pmid:9490019
Mizutani Y et al. Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation. 2004 FEBS Lett. pmid:15063729
Hui EK and Yung BY Cell cycle phase-dependent effect of retinoic acid on the induction of granulocytic differentiation in HL-60 promyelocytic leukemia cells. Evidence for sphinganine potentiation of retinoic acid-induced differentiation. 1993 FEBS Lett. pmid:7680007
Alemany R et al. Depolarisation induces rapid and transient formation of intracellular sphingosine-1-phosphate. 2001 FEBS Lett. pmid:11741596
Samuel GH et al. Autocrine transforming growth factor β signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts. 2010 Fibrogenesis Tissue Repair pmid:21134273
Shephard GS et al. Biomarkers of exposure to fumonisin mycotoxins: a review. 2007 Food Addit Contam pmid:17886192
Garren L et al. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1. 2001 Food Addit Contam pmid:11552753
Kodell RL et al. A mechanistic approach to modelling the risk of liver tumours in mice exposed to fumonisin B1 in the diet. 2001 Food Addit Contam pmid:11304033
Delongchamp RR and Young JF Tissue sphinganine as a biomarker of fumonisin-induced apoptosis. 2001 Food Addit Contam pmid:11304034
Qiu M and Liu X Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1. 2001 Food Addit Contam pmid:11304035
Cano-Sancho G et al. Sphinganine and sphingosine levels and ratio in urine and blood samples from a Catalonian population, Spain. 2011 Food Addit Contam Part A Chem Anal Control Expo Risk Assess pmid:21644119
van der Westhuizen L et al. Sphingoid base levels in humans consuming fumonisin-contaminated maize in rural areas of the former Transkei, South Africa: a cross-sectional study. 2008 Food Addit Contam Part A Chem Anal Control Expo Risk Assess pmid:19680846
Xu L et al. Evaluation of fumonisin biomarkers in a cross-sectional study with two high-risk populations in China. 2010 Food Addit Contam Part A Chem Anal Control Expo Risk Assess pmid:20589550
van der Westhuizen L et al. The effect of a single gavage dose of fumonisin B(2) on the sphinganine and sphingosine concentrations in vervet monkeys. 2001 Food Chem. Toxicol. pmid:11313111
Solfrizzo M et al. Ineffectiveness of activated carbon in reducing the alteration of sphingolipid metabolism in rats exposed to fumonisin-contaminated diets. 2001 Food Chem. Toxicol. pmid:11313118
Rentz SS et al. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells. 2005 Food Chem. Toxicol. pmid:15582204
Dresden Osborne C et al. Host resistance to Trypanosoma cruzi infection is enhanced in mice fed Fusarium verticillioides (=F. moniliforme) culture material containing fumonisins. 2002 Food Chem. Toxicol. pmid:12419693
Osuchowski MF et al. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier. 2005 Food Chem. Toxicol. pmid:15913876
van der Westhuizen L et al. Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. 1999 Food Chem. Toxicol. pmid:10654591
Collins TF et al. Effects of fumonisin B1 in pregnant rats. 1998 Food Chem. Toxicol. pmid:9662415
van der Westhuizen L et al. Individual fumonisin exposure and sphingoid base levels in rural populations consuming maize in South Africa. 2010 Food Chem. Toxicol. pmid:20363278
Burns TD et al. Fumonisin concentrations and in vivo toxicity of nixtamalized Fusarium verticillioides culture material: evidence for fumonisin-matrix interactions. 2008 Food Chem. Toxicol. pmid:18602734
Denli M et al. Efficacy of AdiDetoxâ„¢ in reducing the toxicity of fumonisin B1 in rats. 2015 Food Chem. Toxicol. pmid:25660482
Hahn I et al. Effects of orally administered fumonisin B₁ (FB₁), partially hydrolysed FB₁, hydrolysed FB₁ and N-(1-deoxy-D-fructos-1-yl) FB₁ on the sphingolipid metabolism in rats. 2015 Food Chem. Toxicol. pmid:25475052
Theumer MG et al. Subchronic mycotoxicoses in rats. Histopathological changes and modulation of the sphinganine to sphingosine (Sa/So) ratio imbalance induced by Fusarium verticillioides culture material, due to the coexistence of aflatoxin B1 in the diet. 2008 Food Chem. Toxicol. pmid:18079032
He Q et al. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity. 2005 Food Chem. Toxicol. pmid:15811577
Ciacci-Zanella JR et al. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells. 1998 Sep-Oct Food Chem. Toxicol. pmid:9737426
van der Westhuizen L et al. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds. 1998 Food Chem. Toxicol. pmid:9674957
Galvano F et al. DNA damage in human fibroblasts exposed to fumonisin B(1). 2002 Food Chem. Toxicol. pmid:11731033
Nimrichter L and Rodrigues ML Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials. 2011 Front Microbiol pmid:22025918
Bensaci MF et al. Fungicidal Activities and Mechanisms of Action of Pseudomonas syringae pv. syringae Lipodepsipeptide Syringopeptins 22A and 25A. 2011 Front Microbiol pmid:22046175
Berkey R et al. Sphingolipids and plant defense/disease: the "death" connection and beyond. 2012 Front Plant Sci pmid:22639658
Guo L and Wang X Crosstalk between Phospholipase D and Sphingosine Kinase in Plant Stress Signaling. 2012 Front Plant Sci pmid:22639650
Kedderis LB et al. Toxicity of the protein kinase C inhibitor safingol administered alone and in combination with chemotherapeutic agents. 1995 Fundam Appl Toxicol pmid:7665004
Katsuma S et al. Signalling mechanisms in sphingosine 1-phosphate-promoted mesangial cell proliferation. 2002 Genes Cells pmid:12485162
Kihara A et al. Transmembrane topology of sphingoid long-chain base-1-phosphate phosphatase, Lcb3p. 2003 Genes Cells pmid:12786943
Kariya Y et al. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. 2005 Genes Cells pmid:15938718
Henry SA et al. Metabolism and regulation of glycerolipids in the yeast Saccharomyces cerevisiae. 2012 Genetics pmid:22345606
Li S et al. basA regulates cell wall organization and asexual/sexual sporulation ratio in Aspergillus nidulans. 2007 Genetics pmid:17409079
Vitkup D et al. Influence of metabolic network structure and function on enzyme evolution. 2006 Genome Biol. pmid:16684370
Frank S et al. Structural characterization of Schistosoma mansoni adult worm glycosphingolipids reveals pronounced differences with those of cercariae. 2012 Glycobiology pmid:22241826
Gillard BK et al. Pathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments. 1996 Glycobiology pmid:8991507
Tanaka K et al. Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco-2 cells. 2014 Glycoconj. J. pmid:24310545
Dobrzyń A and Górski J Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat. 2002 Horm. Metab. Res. pmid:12384830
Knapp P et al. Ceramides, sphinganine, sphingosine and acid sphingomyelinases in the human umbilical cord blood. 2005 Horm. Metab. Res. pmid:16034716